Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Semaglutide is a GLP-1 receptor agonist medication prescribed to individuals with type 2 diabetes, obesity, or overweight
Retatrutide is an investigational compound and is not approved for human use in any jurisdiction as of April 2026
Research Applications Comprehensive musculoskeletal repair research Tendon and ligament regeneration studies Wound healing and skin repair models Inflammation modulation research Synergistic dual-peptide mechanism studies Quality Specifications Purity: 98% (HPLC verified) Compound: BPC-157 + TB-500 Molecular Weight: 1419.5 Da / 2113.4 Da Form: Lyophilized powder Origin: Made in the USA Testing: Third-party tested in a US laboratory Storage: -20C, protect from light COA: Batch-specific, ISO-accredited laboratory Frequently Asked Questions Q: Why combine BPC-157 and TB-500
The weight loss gap between these medications reflects their distinct mechanisms
The pharmaceutical dosage form of Health Canada was 16%, and for the U.S
US$ 23.21
US$ 24.74
US$ 23.96
US$ 20.78
